A novel cell transplantation protocol and its application to an ALS mouse model

Area of Science:

• Neuroscience
• Regenerative Medicine
• Cell Therapy

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease impacting motor neurons.
• The widespread nature of motor neurons presents challenges for cell transplantation therapies.
• Developing effective delivery methods for cell-based treatments is crucial for ALS.

Purpose of the Study:

• To evaluate the safety and efficacy of intrathecal cell transplantation via the fourth cerebral ventricle in a mouse model of ALS.
• To assess the distribution and survival of transplanted olfactory ensheathing cells (OECs) and mesenchymal stem cells (MSCs).

Main Methods:

• Developed a novel cell transplantation technique targeting the fourth cerebral ventricle in mice.
• Utilized mouse olfactory ensheathing cells (OECs) and rat mesenchymal stem cells (MSCs) as donor cells.
• Assessed cell distribution, survival, and clinical outcomes in wild-type and ALS model mice.

Main Results:

• Transplanted OECs showed wide distribution and survival up to 100 days in wild-type mice.
• OEC transplantation in ALS mice had no adverse effects but did not significantly alter clinical outcomes.
• Mesenchymal stem cell (MSC) transplantation in female ALS mice resulted in a statistically significant increase in disease duration.

Conclusions:

• Intrathecal transplantation is a viable method for delivering donor cells throughout the central nervous system.
• MSC transplantation demonstrated a potential therapeutic benefit in female ALS mouse models.
• Further research is needed to optimize conditions for enhanced therapeutic outcomes in ALS treatment.